A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans
See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…
Certara2026 年 7 月 20 日
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis
Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…
Certara2026 年 7 月 16 日
When to Conduct Hepatic Impairment Studies and When Modeling May be Enough
How to decide if a hepatic impairment study is required, choose the right study design,…
Certara2026 年 7 月 13 日
Dosimetry for Radiopharmaceutical Therapy: From Measurement to Dose Justification
Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…
Hunter Stephens, PhD2026 年 7 月 7 日
5 Key Principles of Modern PK/PD in 2026
Explore other Phoenix solutions to enhance your PK/PD workflow and discover how Phoenix helps you…
Certara2026 年 6 月 30 日
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
Certara2026 年 6 月 26 日
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development
Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…
Danielle Pillsbury2026 年 6 月 23 日
